← FDA Drug Approvals (Drugs@FDA)

PAVBLU

BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2024-08-23

Drug application

FDA Application #
BLA761298
Application type
Biologics License Application
Brand name
PAVBLU
Generic name
AFLIBERCEPT-AYYH
Active ingredients
AFLIBERCEPT-AYYH
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AMGEN INC
Manufacturer
Amgen, Inc
First approval
2024-08-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown